Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients

Summary

Hyperuricemia is not infrequently encountered among hemodialysis patients. However, there is no clear data about use of febuxostat among hemodialysis patients, apart from very small case series. The aim of this study is to investigate the efficacy of using febuxostat for the treatment of Hyperuricemia among hemodialysis patients.

Timeline

Start

2017-01-01

Primary completion

2017-04-01

Completion

2017-05-01

Drugs

Indications

No indication recorded.